ESRD Bundling Debate Shifts To Congress With Receipt Of CMS Report
Executive Summary
Congress will start looking at the specifics of how to bundle payment for a variety of services related to end-stage renal disease treatment, now that CMS has issued a report on the subject
You may also be interested in...
Patient-Reported Outcomes Are Key To Understanding Success of Bundled Payments – NPC’s Dubois
Experience with the end-stage renal disease prospective payment system reveals a valuable lesson – that patient-related quality metrics are needed to fully assess the impact the system has on the patient, something that will be valuable when bundling is considered for treatments where drug costs are significant.
Possible Legislation Regarding ESA Administration On The Horizon
A recent report from the HHS Office of Inspector General regarding erythropoiesis-stimulating agent administration to patients with chronic kidney failure could be laying the foundation for legislative action in the coming year, a staffer for House Ways and Means Health Subcommittee Chairman Pete Stark, D-Calif., said
Possible Legislation Regarding ESA Administration On The Horizon
A recent report from the HHS Office of Inspector General regarding erythropoiesis-stimulating agent administration to patients with chronic kidney failure could be laying the foundation for legislative action in the coming year, a staffer for House Ways and Means Health Subcommittee Chairman Pete Stark, D-Calif., said